Lista de obras -

An Analysis of the Use of Complementary and Alternative Therapies in Patients with Breast Cancer.

artículo científico publicado en 2009

Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

artículo científico

Cardiac rhabdomyosarcoma of the left atrium

artículo científico publicado en 2014

Cisplatin plus gemcitabine chemotherapy in taxane/anthracycline-resistant metastatic breast cancer.

artículo científico publicado en 2009

Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients?

artículo científico publicado en 2013

Clinicopathologic and demographic evaluation of triple- negative breast cancer patients among a turkish patient population: a single center experience

artículo científico

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

artículo científico publicado en 2014

Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors?

artículo científico publicado en 2013

Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines

artículo científico publicado en 2014

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.

artículo científico publicado en 2008

Intramammary lymph node metastasis in a patient with ovarian carcinoma and a brief review of the literature

artículo científico publicado en 2012

Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: a case presentation and a brief review of the literature

artículo científico

Malignant fibrous histiocytoma of the spermatic cord in a patient with polycystic kidney disease; review of the literature

artículo científico publicado en 2012

Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy

artículo científico publicado en 2012

One-day DCF regimen in patients with metastatic gastric cancer

artículo científico publicado en 2013

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination.

artículo científico publicado en 2009

Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs

artículo científico publicado en 2013

Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol

artículo científico publicado en 2008

Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha

artículo científico publicado en 2013

Prognostic evaluation of breast cancer patients with evident bone marrow metastasis

artículo científico publicado en 2014

Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results

artículo científico publicado en 2013

Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

artículo científico publicado en 2009

Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer

scientific article published on 01 January 2012

Skin and maxillary sinus involvement of colon cancer

artículo científico publicado en 2014

Synchronous appearance of a high-grade neuroendocrine carcinoma of the ampulla vater and sigmoid colon adenocarcinoma.

artículo científico publicado en 2013

The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival ⬇️

artículo científico publicado el 23 de agosto de 2012

The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer

artículo científico publicado en 2013

The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer

artículo científico publicado en 2014

Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab?

artículo científico publicado en 2014

Lista de obras de

An Analysis of the Use of Complementary and Alternative Therapies in Patients with Breast Cancer.

Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

Cardiac rhabdomyosarcoma of the left atrium

Cisplatin plus gemcitabine chemotherapy in taxane/anthracycline-resistant metastatic breast cancer.

Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients?

Clinicopathologic and demographic evaluation of triple- negative breast cancer patients among a turkish patient population: a single center experience

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors?

Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.

Intramammary lymph node metastasis in a patient with ovarian carcinoma and a brief review of the literature

Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: a case presentation and a brief review of the literature

Malignant fibrous histiocytoma of the spermatic cord in a patient with polycystic kidney disease; review of the literature

Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy

One-day DCF regimen in patients with metastatic gastric cancer

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination.

Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs

Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol

Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha

Prognostic evaluation of breast cancer patients with evident bone marrow metastasis

Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results

Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer

Skin and maxillary sinus involvement of colon cancer

Synchronous appearance of a high-grade neuroendocrine carcinoma of the ampulla vater and sigmoid colon adenocarcinoma.

The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival ⬇️

The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer

The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer

Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab?